FLORIA
Natural health product licensed in Canada
- Other names
- FLORIA V
- Licence holder
- Technologies Yad Inc.
- NPN or DIN-HM
- 80138268
- Status
- Active licence
- Licence date
- 31 January 2025
- Revision date
- Not provided
- Form
- Suppositoire
- Route of administration
- Vaginale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Lactobacillus crispatus Source : R0470 | 720 million CFU units/g |
| Lacticaseibacillus Rhamnosus Source : R0011 | 220 million CFU units/g |
| Lactobacillus gasseri Source : HA - 275 | 150 million CFU units/g |
Non-medicinal ingredients
Gélatine, Trehalose, Extrait de levure, Sucrose, Stéarate de magnésium, Maltodextrine, Acide ascorbique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | minimum: 18 years | 1 suppositoire | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of probiotics. Could promote a favorable vaginal flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80138268
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.